1. Home
  2. REBN vs EVOK Comparison

REBN vs EVOK Comparison

Compare REBN & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REBN
  • EVOK
  • Stock Information
  • Founded
  • REBN 2015
  • EVOK 2007
  • Country
  • REBN United States
  • EVOK United States
  • Employees
  • REBN N/A
  • EVOK N/A
  • Industry
  • REBN Restaurants
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • REBN Consumer Discretionary
  • EVOK Health Care
  • Exchange
  • REBN Nasdaq
  • EVOK Nasdaq
  • Market Cap
  • REBN 18.5M
  • EVOK 7.1M
  • IPO Year
  • REBN 2022
  • EVOK 2013
  • Fundamental
  • Price
  • REBN $4.01
  • EVOK $5.37
  • Analyst Decision
  • REBN
  • EVOK
  • Analyst Count
  • REBN 0
  • EVOK 0
  • Target Price
  • REBN N/A
  • EVOK N/A
  • AVG Volume (30 Days)
  • REBN 7.3M
  • EVOK 8.9K
  • Earning Date
  • REBN 03-27-2025
  • EVOK 03-13-2025
  • Dividend Yield
  • REBN N/A
  • EVOK N/A
  • EPS Growth
  • REBN N/A
  • EVOK N/A
  • EPS
  • REBN N/A
  • EVOK N/A
  • Revenue
  • REBN $5,502,528.00
  • EVOK $8,617,036.00
  • Revenue This Year
  • REBN $185.18
  • EVOK $97.35
  • Revenue Next Year
  • REBN $64.55
  • EVOK $99.52
  • P/E Ratio
  • REBN N/A
  • EVOK N/A
  • Revenue Growth
  • REBN 9.70
  • EVOK 100.35
  • 52 Week Low
  • REBN $0.92
  • EVOK $3.54
  • 52 Week High
  • REBN $8.80
  • EVOK $12.32
  • Technical
  • Relative Strength Index (RSI)
  • REBN 59.65
  • EVOK 65.36
  • Support Level
  • REBN $3.64
  • EVOK $4.68
  • Resistance Level
  • REBN $6.41
  • EVOK $5.40
  • Average True Range (ATR)
  • REBN 1.08
  • EVOK 0.33
  • MACD
  • REBN 0.01
  • EVOK 0.07
  • Stochastic Oscillator
  • REBN 48.59
  • EVOK 97.46

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an innovative company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: